www.sciencedirect.com
Open in
urlscan Pro
162.159.136.70
Public Scan
URL:
https://www.sciencedirect.com/science/article/abs/pii/S0223523421008576
Submission: On February 06 via manual from US — Scanned from DE
Submission: On February 06 via manual from US — Scanned from DE
Form analysis
7 forms found in the DOMGET /search#submit
<form class="QuickSearch" action="/search#submit" method="get" aria-label="form">
<div class="search-input">
<div class="search-input-container search-input-container-no-label"><label class="search-input-label"></label><input type="search" id="article-quick-search" name="qs" value="" class="search-input-field" aria-label="undefined "
aria-describedby="article-quick-search-description-message" placeholder="Search ScienceDirect"></div>
<div class="search-input-message-container">
<div aria-live="polite" class="search-input-validation-error"></div>
<div id="article-quick-search-description-message"></div>
</div>
</div><button class="button small u-margin-xs-left button-primary" role="button" aria-disabled="false" type="submit" aria-label="Submit search"><span class="button-text"><svg role="img" focusable="false" viewBox="0 0 100 128" height="20"
width="18.75" class="icon icon-search" aria-label="Search">
<path
d="m19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6l-26.32-26.32c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96s-21.17 4.25-28.88 11.96c-7.72 7.71-11.97 17.97-11.97 28.88s4.25 21.17 11.97 28.88c7.71 7.71 17.97 11.96 28.88 11.96 9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03">
</path>
</svg></span></button><input type="hidden" name="origin" value="article"><input type="hidden" name="zone" value="qSearch">
</form>
POST /getaccess/pii/S0223523417301836
<form class="side-panel-pdf-link" method="post" action="/getaccess/pii/S0223523417301836" target="sd-shopping-cart"><button class="button-link button-link-secondary" type="submit" rel="nofollow"
aria-describedby="recommended-articles-article0-title"><svg role="img" focusable="false" viewBox="0 0 32 32" width="16" height="24" class="icon icon-pdf-multicolor" aria-label="PDF">
<path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path>
<path d="M.167 2.592H22.39V9.72H.166z" stroke="#aaa" stroke-width=".315" fill="#da0000"></path>
<path fill="#fff9f9"
d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638">
</path>
<path
d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z"
fill="#f91d0a"></path>
</svg><span class="button-link-text">Purchase PDF</span></button></form>
POST /getaccess/pii/S0223523421008291
<form class="side-panel-pdf-link" method="post" action="/getaccess/pii/S0223523421008291" target="sd-shopping-cart"><button class="button-link button-link-secondary" type="submit" rel="nofollow"
aria-describedby="recommended-articles-article1-title"><svg role="img" focusable="false" viewBox="0 0 32 32" width="16" height="24" class="icon icon-pdf-multicolor" aria-label="PDF">
<path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path>
<path d="M.167 2.592H22.39V9.72H.166z" stroke="#aaa" stroke-width=".315" fill="#da0000"></path>
<path fill="#fff9f9"
d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638">
</path>
<path
d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z"
fill="#f91d0a"></path>
</svg><span class="button-link-text">Purchase PDF</span></button></form>
POST /getaccess/pii/S022352342100859X
<form class="side-panel-pdf-link" method="post" action="/getaccess/pii/S022352342100859X" target="sd-shopping-cart"><button class="button-link button-link-secondary" type="submit" rel="nofollow"
aria-describedby="recommended-articles-article2-title"><svg role="img" focusable="false" viewBox="0 0 32 32" width="16" height="24" class="icon icon-pdf-multicolor" aria-label="PDF">
<path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path>
<path d="M.167 2.592H22.39V9.72H.166z" stroke="#aaa" stroke-width=".315" fill="#da0000"></path>
<path fill="#fff9f9"
d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638">
</path>
<path
d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z"
fill="#f91d0a"></path>
</svg><span class="button-link-text">Purchase PDF</span></button></form>
POST /getaccess/pii/S0045206818309362
<form class="side-panel-pdf-link" method="post" action="/getaccess/pii/S0045206818309362" target="sd-shopping-cart"><button class="button-link button-link-secondary" type="submit" rel="nofollow"
aria-describedby="recommended-articles-article3-title"><svg role="img" focusable="false" viewBox="0 0 32 32" width="16" height="24" class="icon icon-pdf-multicolor" aria-label="PDF">
<path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path>
<path d="M.167 2.592H22.39V9.72H.166z" stroke="#aaa" stroke-width=".315" fill="#da0000"></path>
<path fill="#fff9f9"
d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638">
</path>
<path
d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z"
fill="#f91d0a"></path>
</svg><span class="button-link-text">Purchase PDF</span></button></form>
POST /getaccess/pii/S0968089616300219
<form class="side-panel-pdf-link" method="post" action="/getaccess/pii/S0968089616300219" target="sd-shopping-cart"><button class="button-link button-link-secondary" type="submit" rel="nofollow"
aria-describedby="recommended-articles-article4-title"><svg role="img" focusable="false" viewBox="0 0 32 32" width="16" height="24" class="icon icon-pdf-multicolor" aria-label="PDF">
<path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path>
<path d="M.167 2.592H22.39V9.72H.166z" stroke="#aaa" stroke-width=".315" fill="#da0000"></path>
<path fill="#fff9f9"
d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638">
</path>
<path
d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z"
fill="#f91d0a"></path>
</svg><span class="button-link-text">Purchase PDF</span></button></form>
POST /getaccess/pii/S0223523421003354
<form class="side-panel-pdf-link" method="post" action="/getaccess/pii/S0223523421003354" target="sd-shopping-cart"><button class="button-link button-link-secondary" type="submit" rel="nofollow"
aria-describedby="recommended-articles-article5-title"><svg role="img" focusable="false" viewBox="0 0 32 32" width="16" height="24" class="icon icon-pdf-multicolor" aria-label="PDF">
<path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path>
<path d="M.167 2.592H22.39V9.72H.166z" stroke="#aaa" stroke-width=".315" fill="#da0000"></path>
<path fill="#fff9f9"
d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638">
</path>
<path
d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z"
fill="#f91d0a"></path>
</svg><span class="button-link-text">Purchase PDF</span></button></form>
Text Content
JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Skip to main contentSkip to article ScienceDirect * Journals & Books * * Search RegisterSign in View PDF * Access through your institution * Purchase PDF OUTLINE 1. Highlights 2. Abstract 3. Graphical abstract 4. Keywords 5. 1. Introduction 6. 2. Results and Discussion 7. 3. Conclusion 8. 4. Experimental 9. Conflicts of interest 10. Declaration of competing interest 11. Acknowledgement 12. Appendix A. Supplementary data 13. References Show full outline CITED BY (5) FIGURES (13) 1. 2. 3. 4. 5. 6. Show all figures TABLES (2) 1. Table 1 2. Table 2 EXTRAS (1) 1. Multimedia component 1 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Volume 228, 15 January 2022, 114008 NATURAL INSPIRED LIGUSTRAZINE-BASED SLC-0111 ANALOGUES AS NOVEL CARBONIC ANHYDRASE INHIBITORS Author links open overlay panelDiaaeldin M. Elimam a b, Wagdy M. Eldehna c, Rofaida Salem c, Alessandro Bonardi d e, Alessio Nocentini d, Sara T. Al-Rashood f, Mahmoud M. Elaasser g, Paola Gratteri e, Claudiu T. Supuran d, Heba Abdelrasheed Allam h Show more Outline Add to Mendeley Share Cite https://doi.org/10.1016/j.ejmech.2021.114008Get rights and content HIGHLIGHTS • New series of Ligustrazine-based sulfonamides were designed and synthesized. • Inhibitory activities of all derivatives were evaluated toward hCA I, II, IX and XII isoforms. • The primary sulfonamides efficiently inhibited hCA IX and XII in the sub-micromolar ranges. • Compounds 6c and 18 were examined for its potential anticancer and pro-apoptotic activities. • A molecular modelling study was performed to unveil the plausible binding interactions. ABSTRACT Ligustrazine is the principle bioactive alkaloid in the widely-used Chinese herb Chuan Xiong rhizome. Herein, a series of novel derivatives has been designed as human carbonic anhydrases inhibitors (hCAIs) starting from the natural product Ligustrazine inserted as a tail instead of the 4-fluorophenyl tail of SLC-0111, a front-runner selective hCA IX inhibitor currently in clinical trials as antitumor/antimetastatic agent. Other derivatives were designed via incorporation of different linkers, of amide and ester type, or incorporation of different zinc anchoring groups such as secondary sulfamoyl and carboxylic acid functionalities. The newly designed molecules were prepared following different synthetic pathways, and were assessed for their inhibitory actions against four isoforms: the widespread cytosolic (hCA I and II), and the transmembrane tumor-related (hCA IX and XII). The primary sulfonamides efficiently inhibited the target hCA IX and hCA XII in the nanomolar range (KIs: 6.2–951.5 nM and 3.3–869.3 nM, respectively). The most selective hCA IX inhibitors 6c and 18 were assessed for their potential anticancer effects, and displayed anti-proliferative activity against MCF-7 cancer cell line with IC50s of 11.9 and 36.7 μM, respectively. Molecular modelling studies unveiled the relationship between structural features and inhibitory profiles against the off-target hCA II and the target, tumor-related isoforms hCA IX and XII. GRAPHICAL ABSTRACT 1. Download : Download high-res image (253KB) 2. Download : Download full-size image * Previous article in issue * Next article in issue KEYWORDS Anticancer agents SLC-0111 analogues Carbonic anhydrase inhibitors Ligustrazine Tail approach Ureido benzenesulfonamides Recommended articles CITED BY (5) * INSIGHTS INTO THE EFFECT OF ELABORATING COUMARIN-BASED ARYL ENAMINONES WITH SULFONAMIDE OR CARBOXYLIC ACID FUNCTIONALITY ON CARBONIC ANHYDRASE INHIBITORY POTENCY AND SELECTIVITY 2022, Bioorganic Chemistry Show abstract Recently, different mechanisms for inhibition of carbonic anhydrases (CAs) have been reported, such as the classical zinc-binding (exerted by sulfonamides and carboxylic acids) as well as occluding the entrance of the CA active site (exerted by coumarins). In this manuscript, we studied the effect of combining the pharmacopheric parts responsible for these two mechanisms on CA inhibitory potency and selectivity through the design and synthesis of novel coumarins tethered with the zinc-binding sulfonamide (5a-f, 11a-b and 13a-b) or carboxylic acid (7a-f) groups. In addition, another set of coumarin derivatives (9a-b) with no zinc-binding group (ZBG) was designed to act as non-classical CA inhibitors. The synthesized coumarins were examined for their inhibitory activities towards four hCA isoforms I, II, IX and XII. Coumarin sulfonamides (5a-f, 11a-b and 13a-b) effectively inhibited both tumor-associated hCA IX (KIs: 8.9–133.5 nM) and hCA XII (KIs: 3.4–42.9 nM) isoforms, whereas coumarin carboxylic acids (7a-f) weakly affected hCA IX (KIs: 0.49–11.2 μM) and hCA XII (KIs: 0.51–10.1 μM) isoforms. The coumarin based inhibitors featuring zinc-binding sulfonamide or carboxylic acid group achieved low to moderate hCA IX/XII selectivity. Interestingly, the ZBG-free coumarin derivatives (9a-b) emerged not only as effective hCA IX (KIs = 93.3 and 63.8 nM, respectively) and hCA XII (KIs = 85.7 and 72.1 nM, respectively) inhibitors, but also as a highly hCA IX/XII selective inhibitors over the off-target hCA I/II isoforms (SIs > 1000). Coumarin 9a was further evaluated for its anti-proliferative effect on MCF-7 and PANC-1 cancer cell lines, as well as its effect on the cell cycle and apoptosis towards MCF-7 cell line. * SYNTHESIS AND ANTICANCER ACTIVITY OF NEW BENZENSULFONAMIDES INCORPORATING S-TRIAZINES AS CYCLIC LINKERS FOR INHIBITION OF CARBONIC ANHYDRASE IX 2022, Scientific Reports * DESIGN AND SYNTHESIS OF BENZOTHIAZOLE-BASED SLC-0111 ANALOGUES AS NEW INHIBITORS FOR THE CANCER-ASSOCIATED CARBONIC ANHYDRASE ISOFORMS IX AND XII 2022, Journal of Enzyme Inhibition and Medicinal Chemistry * ENAMINONE-BASED CARBOXYLIC ACIDS AS NOVEL NON-CLASSICAL CARBONIC ANHYDRASES INHIBITORS: DESIGN, SYNTHESIS AND IN VITRO BIOLOGICAL ASSESSMENT 2022, Journal of Enzyme Inhibition and Medicinal Chemistry * TARGETING CARBONIC ANHYDRASE IX AND XII ISOFORMS WITH SMALL MOLECULE INHIBITORS AND MONOCLONAL ANTIBODIES 2022, Journal of Enzyme Inhibition and Medicinal Chemistry View full text © 2021 Elsevier Masson SAS. All rights reserved. RECOMMENDED ARTICLES * STRUCTURE ACTIVITY STUDY OF CARBONIC ANHYDRASE IX: SELECTIVE INHIBITION WITH UREIDO-SUBSTITUTED BENZENESULFONAMIDES European Journal of Medicinal Chemistry, Volume 132, 2017, pp. 184-191 Mam Y. Mboge, …, Robert McKenna Purchase PDF * STRAIGHTFORWARD ACCESS TO NOVEL MITOCHONDRIOTROPICS DERIVED FROM 2-ARYLETHANOL AS POTENT AND SELECTIVE ANTIPROLIFERATIVE AGENTS European Journal of Medicinal Chemistry, Volume 228, 2022, Article 113980 Francisco J. Hicke, …, José G. Fernández-Bolaños Purchase PDF * NOVEL 2-PHENYL-3-(PYRIDIN-2-YL) THIAZOLIDIN-4-ONE DERIVATIVES AS POTENT INHIBITORS FOR PROLIFERATION OF OSTEOSARCOMA CELLS IN VITRO AND IN VIVO European Journal of Medicinal Chemistry, Volume 228, 2022, Article 114010 Yaqi Deng, …, Shunying Liu Purchase PDF * SLC-0111 ENAMINONE ANALOGS, 3/4-(3-ARYL-3-OXOPROPENYL) AMINOBENZENESULFONAMIDES, AS NOVEL SELECTIVE SUBNANOMOLAR INHIBITORS OF THE TUMOR-ASSOCIATED CARBONIC ANHYDRASE ISOFORM IX Bioorganic Chemistry, Volume 83, 2019, pp. 549-558 Wagdy M. Eldehna, …, Claudiu T. Supuran Purchase PDF * KINETIC AND X-RAY CRYSTALLOGRAPHIC INVESTIGATIONS ON CARBONIC ANHYDRASE ISOFORMS I, II, IX AND XII OF A THIOUREIDO ANALOG OF SLC-0111 Bioorganic & Medicinal Chemistry, Volume 24, Issue 5, 2016, pp. 976-981 Carrie L. Lomelino, …, Claudiu T. Supuran Purchase PDF * NOVEL BENZENESULFONAMIDES ARYL AND ARYLSULFONE CONJUGATES ADOPTING TAIL/DUAL TAIL APPROACHES: SYNTHESIS, CARBONIC ANHYDRASE INHIBITORY ACTIVITY AND MOLECULAR MODELING STUDIES European Journal of Medicinal Chemistry, Volume 221, 2021, Article 113486 Assem H. Eldeeb, …, Claudiu T. Supuran Purchase PDF Show 3 more articles ARTICLE METRICS Citations * Citation Indexes: 5 Captures * Readers: 8 View details * About ScienceDirect * Remote access * Shopping cart * Advertise * Contact and support * Terms and conditions * Privacy policy We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V. ScienceDirect® is a registered trademark of Elsevier B.V.